Home Amines 21901-29-1
21901-29-1,MFCD00047443
Catalog No.:AA003GB1

21901-29-1 | 2-Amino-6-methyl-3-nitropyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$11.00   $8.00
- +
5g
95%
in stock  
$13.00   $9.00
- +
10g
95%
in stock  
$16.00   $11.00
- +
100g
95%
in stock  
$151.00   $106.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003GB1
Chemical Name:
2-Amino-6-methyl-3-nitropyridine
CAS Number:
21901-29-1
Molecular Formula:
C6H7N3O2
Molecular Weight:
153.1387
MDL Number:
MFCD00047443
SMILES:
[O-][N+](=O)c1ccc(nc1N)C
NSC Number:
16024
Properties
Properties
 
BP:
309.1°C at 760 mmHg  
Form:
Solid  
MP:
147-157 °C  
Refractive Index:
1.6500 (estimate)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
156  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
XLogP3:
1.3  

Upstream Synthesis Route

[1]JournaloftheAmericanChemicalSociety,1947,vol.69,p.63,66

[2]JournalofHeterocyclicChemistry,1996,vol.33,#6,p.1815-1821

[3]JournaloftheAmericanChemicalSociety,1947,vol.69,p.63,66

[4]JournalofHeterocyclicChemistry,1996,vol.33,#6,p.1815-1821

[1]JournaloftheAmericanChemicalSociety,1952,vol.74,p.3828,3830

[2]Patent:EP2366691,2011,A1,

[1]JournalofMedicinalChemistry,1996,vol.39,#6,p.1331-1338

[2]Patent:EP2366691,2011,A1,.Locationinpatent:Page/Pagecolumn11

[3]BioorganicandMedicinalChemistryLetters,1998,vol.8,#22,p.3171-3176

[4]Patent:EP1479681,2004,A1,.Locationinpatent:Page122

[5]Patent:US2002/32187,2002,A1,

[1]JournalofMedicinalChemistry,2018,vol.61,#8,p.3309-3324

[1]Patent:US5977101,1999,A,

Downstream Synthesis Route

[1]JournalofFluorineChemistry,2011,vol.132,p.541-547

[2]ArchivderPharmazie,1995,vol.328,p.247-255

[3]ArchivderPharmazie,1995,vol.328,p.247-255

[4]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1952,vol.72,p.434    Chem.Abstr.,1953,p.6404

[5]JournalofMolecularStructure,2013,vol.1043,p.15-27

[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP1479681,2004,A1Locationinpatent:Page122

[2]CurrentPatentAssignee:ASSTRAZENECA;OTSUKAHOLDINGSCOLTD-WO2006/65204,2006,A1Locationinpatent:Page/Pagecolumn96-97

[3]Moreau,RobertJ.;Skepper,ColinK.;Appleton,BrentA.;Blechschmidt,Anke;Balibar,CarlJ.;Benton,BretM.;Drumm,JosephE.;Feng,BrianY.;Geng,Mei;Li,Cindy;Lindvall,MikaK.;Lingel,Andreas;Lu,Yipin;Mamo,Mulugeta;Mergo,Wosenu;Polyakov,Valery;Smith,ThomasM.;Takeoka,Kenneth;Uehara,Kyoko;Wang,Lisha;Wei,Jun-Rong;Weiss,AndrewH.;Xie,Lili;Xu,Wenjian;Zhang,Qiong;DeVicente,Javier[JournalofMedicinalChemistry,2018,vol.61,#8,p.3309-3324]

[4]Keenan,RichardM.;Lago,M.Amparo;Miller,WilliamH.;Ali,FadiaE.;Cousins,RussellD.;Hall,LeonB.;Hwang,Shing-Mei;Jakas,DaliaR.;Kwon,Chet;Louden,Calvert;Nguyen,ThomasT.;Ohlstein,EliotH.;Rieman,DavidJ.;Ross,StevenT.;Samanen,JamesM.;Smith,BrianR.;Stadel,Jeffrey;Takata,DennisT.;Vickery,Lynne;Yuan,CatherineC.K.;Yue,Tian-Li[BioorganicandMedicinalChemistryLetters,1998,vol.8,#22,p.3171-3176]

[5]Singh,MalvinderP.;Bathini,Yadagiri[Heterocycles,1993,vol.36,#5,p.971-985]

[6]Troschutz;Luckel[ArchivderPharmazie,1992,vol.325,#9,p.617-619]

[7]CurrentPatentAssignee:SHANGHAIANGRUIPHARMACEUTICALTECH;HISUNGROUPCO.,LTD.-CN113527261,2021,ALocationinpatent:Paragraph0256-0262

[8]CurrentPatentAssignee:SANOFI-WO2014/144737,2014,A1Locationinpatent:Paragraph00803

[9]Bavin[CanadianJournalofChemistry,1958,vol.36,p.238]

[10]Lappin;Slezak[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2806]

[11]Mantlo,NathanB.;Chakravarty,PrasunK.;Ondeyka,DebraL.;Siegl,PeterK.S.;Chang,RaymondS.;etal.[JournalofMedicinalChemistry,1991,vol.34,#9,p.2919-2922]

[12]Ohmori;Kubota;Shimizu-Sasamata;Okada;Sakamoto[JournalofMedicinalChemistry,1996,vol.39,#6,p.1331-1338]

[13]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2002/32187,2002,A1

[14]CurrentPatentAssignee:MERCK&COINC-EP2102201,2010,B1Locationinpatent:Page/Pagecolumn147

[15]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG;F.LLIGANCIA&C.SPA-WO2014/19979,2014,A1Locationinpatent:Page/Pagecolumn105-106

[16]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG;F.LLIGANCIA&C.SPA-US2014/45856,2014,A1Locationinpatent:Paragraph0611-0614

[17]Abou-Elkhair,RehamA.I.;Hassan,AbdallaE.A.;Boykin,DavidW.;Wilson,W.David[OrganicLetters,2016,vol.18,#18,p.4714-4717]

[18]Skepper,ColinK.;Moreau,RobertJ.;Appleton,BrentA.;Benton,BretM.;Drumm,JosephE.;Feng,BrianY.;Geng,Mei;Hu,Cheng;Li,Cindy;Lingel,Andreas;Lu,Yipin;Mamo,Mulugeta;Mergo,Wosenu;Mostafavi,Mina;Rath,ChristopherM.;Steffek,Micah;Takeoka,KennethT.;Uehara,Kyoko;Wang,Lisha;Wei,Jun-Rong;Xie,Lili;Xu,Wenjian;Zhang,Qiong;DeVicente,Javier[JournalofMedicinalChemistry,2018,vol.61,#8,p.3325-3349]

[19]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US5977101,1999,A

[1]Patent:EP2366691,2011,A1.Locationinpatent:Page/Pagecolumn11

[2]JournaloftheAmericanChemicalSociety,1952,vol.74,p.3828,3830

[1]JournaloftheAmericanChemicalSociety,1947,vol.69,p.63,66

[2]JournalofHeterocyclicChemistry,1996,vol.33,p.1815-1821

[3]JournaloftheAmericanChemicalSociety,1947,vol.69,p.63,66

[4]JournalofHeterocyclicChemistry,1996,vol.33,p.1815-1821

[1]Mertens,Hubert;Troschuetz,Reinhard;Roth,HermannJ.[LiebigsAnnalenderChemie,1986,#2,p.380-383]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 21901-29-1
Tags:21901-29-1 Molecular Formula|21901-29-1 MDL|21901-29-1 SMILES|21901-29-1 2-Amino-6-methyl-3-nitropyridine |Organic_Building_Blocks